Global Atrophic Gastritis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 107 pages | ID: GC4B0EE5610GEN
GlobalInfoResearch

Abstracts

Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity directed against gastric glandular cell. Symptoms include stomach pain, loss of appetite, nausea, unexpected weight loss, iron deficiency anemia. There is a high chance for the development of pernicious anemia in autoimmune atrophic gastritis Individual due to the loss of anti-intrinsic antibodies and parietal cell mass. Atrophic gastritis associated with H. Pylori are at high risk of developing gastric carcinoma and is frequently asymptomatic. Individuals associated with chronic atrophic gastritis develop hypergastrinemia and low gastric acid output which may lead to carcinoid tumors and enterochromaffin-like cell hyperplasia. Atrophic gastritis develops at childhood and if, it is left untreated atrophic gastritis progress throughout the lifespan. Treatment mainly includes antibiotics for eliminating H. Pylori bacteria. Symptomatic treatment includes vitamin B-12 injections. Proton pump inhibitors used to control the acidity of the stomach. Autoimmune atrophic gastritis associated with gastric polyps, pernicious anemia, and adenocarcinoma. Atrophic gastritis diagnosed by low levels of B-12, low levels of pepsinogen, high levels of gastrin and intrinsic factors.

SCOPE OF THE REPORT:

This report studies the Atrophic Gastritis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Atrophic Gastritis Treatment market by product type and applications/end industries.
Atrophic gastritis is associated with loss of gastric gland and is a progressive condition with the replacement of metaplasia. It is asymptomatic and associated with large complications like gastric carcinoma, hyperplasia, hypergastrinemia, increased risk of heart attack in elderly. The frequency of atrophic gastritis is unknown due to it is mostly asymptomatic. Atrophic gastritis is extremely common and is highly prevalent in different parts of the globe. In atrophic gastritis, eradication of H. Pylori is highly complicated, and it requires follow-up for several years. Eradication of H. Pylori reduces the risk of developing cancers in late stages. Mortality and morbidity associated with atrophic gastritis are depended on underlying complications of diseases. Atrophic gastritis requires a continuous management because recurrence of illness is high. All these factors act as a driver in the robust growth of the atrophic gastritis treatment market.
The global Atrophic Gastritis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Atrophic Gastritis Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Takeda Pharmaceutical Company Limited
• PERNIX Therapeutics
• Perrigo Pharmaceutical
• Teva Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Coating Agents
• Antibiotics
• Vitamin B-12

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Contents

1 ATROPHIC GASTRITIS TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Atrophic Gastritis Treatment
1.2 Classification of Atrophic Gastritis Treatment by Types
  1.2.1 Global Atrophic Gastritis Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Atrophic Gastritis Treatment Revenue Market Share by Types in 2017
  1.2.3 Coating Agents
  1.2.4 Antibiotics
  1.2.5 Vitamin B-12
1.3 Global Atrophic Gastritis Treatment Market by Application
  1.3.1 Global Atrophic Gastritis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Drug Stores
  1.3.5 Online Pharmacies
1.4 Global Atrophic Gastritis Treatment Market by Regions
  1.4.1 Global Atrophic Gastritis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Atrophic Gastritis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Atrophic Gastritis Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Takeda Pharmaceutical Company Limited
  2.1.1 Business Overview
  2.1.2 Atrophic Gastritis Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 PERNIX Therapeutics
  2.2.1 Business Overview
  2.2.2 Atrophic Gastritis Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 PERNIX Therapeutics Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Perrigo Pharmaceutical
  2.3.1 Business Overview
  2.3.2 Atrophic Gastritis Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Perrigo Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical
  2.4.1 Business Overview
  2.4.2 Atrophic Gastritis Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Teva Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ATROPHIC GASTRITIS TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Atrophic Gastritis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Atrophic Gastritis Treatment Players Market Share
  3.2.2 Top 10 Atrophic Gastritis Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL ATROPHIC GASTRITIS TREATMENT MARKET SIZE BY REGIONS

4.1 Global Atrophic Gastritis Treatment Revenue and Market Share by Regions
4.2 North America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ATROPHIC GASTRITIS TREATMENT REVENUE BY COUNTRIES

5.1 North America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
5.2 USA Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE ATROPHIC GASTRITIS TREATMENT REVENUE BY COUNTRIES

6.1 Europe Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
6.2 Germany Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ATROPHIC GASTRITIS TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
7.2 China Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ATROPHIC GASTRITIS TREATMENT REVENUE BY COUNTRIES

8.1 South America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ATROPHIC GASTRITIS TREATMENT BY COUNTRIES

9.1 Middle East and Africa Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL ATROPHIC GASTRITIS TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Atrophic Gastritis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Atrophic Gastritis Treatment Market Forecast by Type (2018-2023)
10.3 Coating Agents Revenue Growth Rate (2013-2023)
10.4 Antibiotics Revenue Growth Rate (2013-2023)
10.5 Vitamin B-12 Revenue Growth Rate (2013-2023)

11 GLOBAL ATROPHIC GASTRITIS TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Atrophic Gastritis Treatment Revenue Market Share by Application (2013-2018)
11.2 Atrophic Gastritis Treatment Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL ATROPHIC GASTRITIS TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Atrophic Gastritis Treatment Market Size Forecast (2018-2023)
12.2 Global Atrophic Gastritis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Atrophic Gastritis Treatment Picture
Table Product Specifications of Atrophic Gastritis Treatment
Table Global Atrophic Gastritis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Atrophic Gastritis Treatment Revenue Market Share by Types in 2017
Figure Coating Agents Picture
Figure Antibiotics Picture
Figure Vitamin B-12 Picture
Table Global Atrophic Gastritis Treatment Revenue (Million USD) by Application (2013-2023)
Figure Atrophic Gastritis Treatment Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Drug Stores Picture
Figure Online Pharmacies Picture
Table Global Market Atrophic Gastritis Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Type and Applications
Table Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table PERNIX Therapeutics Basic Information, Manufacturing Base and Competitors
Table PERNIX Therapeutics Atrophic Gastritis Treatment Type and Applications
Table PERNIX Therapeutics Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Perrigo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Perrigo Pharmaceutical Atrophic Gastritis Treatment Type and Applications
Table Perrigo Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Atrophic Gastritis Treatment Type and Applications
Table Teva Pharmaceutical Atrophic Gastritis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Atrophic Gastritis Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue Share by Players (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Share by Players in 2016
Figure Global Atrophic Gastritis Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Atrophic Gastritis Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Atrophic Gastritis Treatment Revenue Market Share in 2017
Figure Global Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Market Share by Regions in 2017
Figure North America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure South America Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table North America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
Table North America Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Atrophic Gastritis Treatment Revenue Market Share by Countries in 2017
Figure USA Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table Europe Atrophic Gastritis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Atrophic Gastritis Treatment Revenue Market Share by Countries in 2017
Figure Germany Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure UK Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure France Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Atrophic Gastritis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Atrophic Gastritis Treatment Revenue Market Share by Countries in 2017
Figure China Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure India Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table South America Atrophic Gastritis Treatment Revenue by Countries (2013-2018)
Table South America Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Atrophic Gastritis Treatment Revenue Market Share by Countries in 2017
Figure Brazil Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Atrophic Gastritis Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Atrophic Gastritis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Atrophic Gastritis Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Atrophic Gastritis Treatment Revenue and Growth Rate (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue Share by Type (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Share by Type (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Share by Type in 2017
Table Global Atrophic Gastritis Treatment Revenue Forecast by Type (2018-2023)
Figure Global Atrophic Gastritis Treatment Market Share Forecast by Type (2018-2023)
Figure Global Coating Agents Revenue Growth Rate (2013-2018)
Figure Global Antibiotics Revenue Growth Rate (2013-2018)
Figure Global Vitamin B-12 Revenue Growth Rate (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue by Application (2013-2018)
Table Global Atrophic Gastritis Treatment Revenue Share by Application (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Share by Application (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue Share by Application in 2017
Table Global Atrophic Gastritis Treatment Revenue Forecast by Application (2018-2023)
Figure Global Atrophic Gastritis Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Drug Stores Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Atrophic Gastritis Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Atrophic Gastritis Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Atrophic Gastritis Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
Figure Europe Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
Figure South America Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Atrophic Gastritis Treatment Revenue Market Forecast (2018-2023)